Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1893 (LINC01893) is a long intergenic non-coding RNA, meaning it is a transcribed RNA molecule located between protein-coding genes, and it does not encode a protein. LINC01893 belongs to a molecular class of long non-coding RNAs, a category marked by diverse roles in gene expression regulation, chromatin modification, and potential contributions to disease biology, particularly cancer. Despite the growing recognition of lncRNAs as disease regulators and potential biomarkers, specific functional, disease, or drug-related roles of LINC01893 remain uncharacterized in the current literature and biomedical databases. Further research may clarify its cellular functions or disease relevance. If information about potential function or disease relevance emerges, it would likely parallel the general roles of lncRNAs – such as regulation of transcription, participation in epigenetic modification, or impact as cancer regulators – but this is not yet supported for LINC01893 specifically.
None established – No drugs are known to act on LINC01893, so mechanisms of drug action are not defined.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1893 (LINC01893).